User menu

Influence of Age, Donor-Recipient CYP3A4/5 Genotypes, Fluconazole and Time Post-Transplantation On Tacrolimus Pharmacokinetics in Pediatric Liver Transplantation

Bibliographic reference GUY-VITERBO, Vanessa ; Haufroid, Vincent ; Elens, Laure ; et. al. Influence of Age, Donor-Recipient CYP3A4/5 Genotypes, Fluconazole and Time Post-Transplantation On Tacrolimus Pharmacokinetics in Pediatric Liver Transplantation.World Transplant Congress (San Francisco, CA, du 26/07/2014 au 31/07/2014). In: Transplantation, Vol. 98, no. 1, p. 717-771 (15 juillet 2014)
Permanent URL
  1. Staatz Christine E., Goodman Lucy K., Tett Susan E., Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I : , 10.2165/11317350-000000000-00000
  2. Wallemacq Pierre, Armstrong Victor W, Brunet Merce, Haufroid Vincent, Holt David W, Johnston Atholl, Kuypers Dirk, Meur Yannick Le, Marquet Pierre, Oellerich Michael, Thervet Eric, Toenshoff Burkhand, Undre Nas, Weber Lutz T, Westley Ian S, Mourad Michel, Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference : , 10.1097/ftd.0b013e318198d092
  3. Coelho Tracy, Tredger Michael, Dhawan Anil, Current status of immunosuppressive agents for solid organ transplantation in children : Current status of immunosuppressive agents, 10.1111/j.1399-3046.2012.01644.x
  4. Durand Philippe, Debray Dominique, Kolaci Mikaela, Bouligand Jerome, Furlan Valérie, Fabre Monique, Letierce Alexia, Verstuyft Céline, Becquemont Laurent, Tacrolimus dose requirement in pediatric liver transplantation: influence of CYP3A5 gene polymorphism, 10.2217/pgs.13.87
  5. de Wildt Saskia N., van Schaik Ron H. N., Soldin Offie P., Soldin Steve J., Brojeni Parvaneh Yazdani, van der Heiden Ilse P., Parshuram Chris, Nulman Irena, Koren Gideon, The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation, 10.1007/s00228-011-1083-7
  6. Gijsen Violette, Mital Seema, van Schaik Ron H., Soldin Offie P., Soldin Steven J., van der Heiden Ilse P., Nulman Irena, Koren Gideon, de Wildt Saskia N., Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients, 10.1016/j.healun.2011.08.001
  7. Guy-Viterbo V., Scohy A., Verbeeck R. K., Reding R., Wallemacq P., Musuamba Flora Tshinanu, Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation, 10.1007/s00228-013-1501-0
  8. Knops Noël, Levtchenko Elena, van den Heuvel Bert, Kuypers Dirk, From gut to kidney: Transporting and metabolizing calcineurin-inhibitors in solid organ transplantation, 10.1016/j.ijpharm.2013.05.033
  9. Xue Feng, Han Longzhi, Chen Yikuan, Xi Zhifeng, Li Qigen, Xu Ning, Xia Yun, Streicher Katie, Zhang Jianjun, Xia Qiang, CYP3A5genotypes affect tacrolimus pharmacokinetics and infectious complications in Chinese pediatric liver transplant patients, 10.1111/petr.12216
  10. Abdel Jalil Mariam H., Hawwa Ahmed F., McKiernan Patrick J., Shields Michael D., McElnay James C., Population pharmacokinetic and pharmacogenetic analysis of tacrolimus in paediatric liver transplant patients : Tacrolimus pharmacokinetics in children, 10.1111/bcp.12174
  11. Thervet E, Clin. Pharmacol. Ther., 87, 721 (2010)
  12. Wang D, Guo Y, Wrighton S A, Cooke G E, Sadee W, Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs, 10.1038/tpj.2010.28
  13. Elens L., Bouamar R., Hesselink D. A., Haufroid V., van der Heiden I. P., van Gelder T., van Schaik R. H. N., A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients, 10.1373/clinchem.2011.165613
  14. Gijsen Violette MGJ, van Schaik Ron HN, Elens Laure, Soldin Offie P, Soldin Steven J, Koren Gideon, de Wildt Saskia N, CYP3A4*22andCYP3Acombined genotypes both correlate with tacrolimus disposition in pediatric heart transplant recipients, 10.2217/pgs.13.80
  15. Elens Laure, Capron Arnaud, Kerckhove Valérie Van, Lerut Jan, Mourad Michel, Lison Dominique, Wallemacq Pierre, Haufroid Vincent, 1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation : , 10.1097/fpc.0b013e3282e9a533
  16. Capron Arnaud, Mourad Michel, De Meyer Martine, De Pauw Luc, Eddour Djamila Chaib, Latinne Dominique, Elens Laure, Haufroid Vincent, Wallemacq Pierre, CYP3A5andABCB1polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation, 10.2217/pgs.10.43
  17. Maguire Michelle, Franz Thaddeus, Hains David S., A clinically significant interaction between tacrolimus and multiple proton pump inhibitors in a kidney transplant recipient : Shared metabolism of PPIs and tacrolimus, 10.1111/j.1399-3046.2011.01559.x
  18. Ji Eunhee, Choi Leena, Suh Kyung-Suk, Cho Joo-Youn, Han Nayoung, Oh Jung Mi, Combinational Effect of Intestinal and Hepatic CYP3A5 Genotypes on Tacrolimus Pharmacokinetics in Recipients of Living Donor Liver Transplantation : , 10.1097/tp.0b013e318263700a
  19. Stewart Zoe A., Locke Jayme E., Montgomery Robert A., Singer Andrew L., Cameron Andrew M., Segev Dorry L., ABO-incompatible deceased donor liver transplantation in the United States: A national registry analysis, 10.1002/lt.21723
  20. , Banff schema for grading liver allograft rejection: An international consensus document, 10.1002/hep.510250328
  21. Ventura E., Bonardet A., Pageaux G.P., Mourad G., Cristol J.P., Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring, 10.1016/j.transproceed.2008.12.018
  22. Tempestilli Massimo, Di Stasio Enrico, Basile Maria Rosaria, Elisei Federica, Antonini Mario, Ettorre Giuseppe Maria, Iappelli Massimo, Pucillo Leopoldo Paolo, Low Plasma Concentrations of Albumin Influence the Affinity Column–Mediated Immunoassay Method for the Measurement of Tacrolimus in Blood During the Early Period After Liver Transplantation : , 10.1097/ftd.0b013e318279dfd2
  23. Wallemacq Pierre, Goffinet Jean-Sebastien, OʼMorchoe Susan, Rosiere Thomas, Maine Gregory T, Labalette Myriam, Aimo Giuseppe, Dickson Diana, Schmidt Ed, Schwinzer Reinhard, Schmid Rainer W, Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay : , 10.1097/ftd.0b013e31819c6a37
  24. Baak-Pablo Renee, Dezentje Vincent, Guchelaar Henk-Jan, van der Straaten Tahar, Genotyping of DNA Samples Isolated from Formalin-Fixed Paraffin-Embedded Tissues Using Preamplification, 10.2353/jmoldx.2010.100047
  25. Schwartz George J., Brion Luc P., Spitzer Adrian, The Use of Plasma Creatinine Concentration for Estimating Glomerular Filtration Rate in Infants, Children, and Adolescents, 10.1016/s0031-3955(16)36251-4
  26. Wallin Johan E, Friberg Lena E, Fasth Anders, Staatz Christine E, Population Pharmacokinetics of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Recipients: New Initial Dosage Suggestions and a Model-Based Dosage Adjustment Tool : , 10.1097/ftd.0b013e3181aab02b
  27. Hines R.N., Developmental expression of drug metabolizing enzymes: Impact on disposition in neonates and young children, 10.1016/j.ijpharm.2012.05.079
  29. van den Anker Johannes N., Schwab Matthias, Kearns Gregory L., Developmental Pharmacokinetics, Pediatric Clinical Pharmacology (2011) ISBN:9783642201943 p.51-75, 10.1007/978-3-642-20195-0_2
  30. Kamdem L. K., Contribution of CYP3A5 to the in Vitro Hepatic Clearance of Tacrolimus, 10.1373/clinchem.2005.050047
  32. Elens Laure, Capron Arnaud, van Schaik Ron HN, De Meyer Martine, De Pauw Luc, Eddour Djamila C., Latinne Dominique, Wallemacq Pierre, Mourad Michel, Haufroid Vincent, Impact of CYP3A4*22 Allele on Tacrolimus Pharmacokinetics in Early Period After Renal Transplantation : Toward Updated Genotype-Based Dosage Guidelines, 10.1097/ftd.0b013e318296045b
  33. Gómez-Bravo MA, J. Clin. Pharmacol., 53, 1146 (2013)
  34. Buendia Jefferson A., Bramuglia Guillermo, Staatz Christine E., Effects of Combinational CYP3A5 6986A>G Polymorphism in Graft Liver and Native Intestine on the Pharmacokinetics of Tacrolimus in Liver Transplant Patients : A Meta-Analysis, 10.1097/ftd.0000000000000032
  35. FUKUDO M, YANO I, MASUDA S, GOTO M, UESUGI M, KATSURA T, OGURA Y, OIKE F, TAKADA Y, EGAWA H, Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients, 10.1016/j.clpt.2006.06.008
  36. Tunblad Karin, Lindbom Lars, McFadyen Lynn, Jonsson E. Niclas, Marshall Scott, Karlsson Mats O., The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic data, 10.1007/s10928-008-9099-z